Sinha Vikas
Insider CIK 1337845 · VRNA Director · SRRK Chief Financial Officer · ALVR See Remarks, Director, 10% owner · ALXN SVP & CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SRRK Scholar Rock Holding Corp | S Sale | 2026-04-16 | 2026-04-20 | 10,410 | $49.57 | $516.0K | 619,856 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2026-02-09 | 2026-02-11 | 47,021 | — | $0 | 630,266 | SEC↗ |
| SRRK Scholar Rock Holding Corp | S Sale | 2026-01-13 | 2026-01-15 | 16,755 | $42.70 | $715.4K | 583,245 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 384 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 94,112 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-08-01 | 2025-08-05 | 4,328 | $13.14 | $56.9K | 94,112 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 98,440 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-05-20 | 2025-05-22 | 160,000 | — | $0 | 384 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-05-20 | 2025-05-22 | 160,000 | $0.50 | $80.0K | 234,440 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-05-20 | 2025-05-22 | 160,000 | $9.39 | $1.50M | 74,440 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award deriv | 2025-05-02 | 2025-05-06 | 110,067 | — | $0 | 110,067 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-01 | 4,952 | — | $0 | 195,048 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-01 | 15,048 | — | $0 | 80,952 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-22 | 120,384 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-04-29 | 2025-05-22 | 39,616 | — | $0 | 160,384 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-01 | 15,048 | $1.70 | $25.6K | 89,488 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-01 | 4,952 | $0.50 | $2.5K | 79,392 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-01 | 15,048 | $8.92 | $134.2K | 74,440 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-01 | 4,952 | $8.92 | $44.2K | 74,440 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-22 | 39,616 | $0.50 | $19.8K | 114,056 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-04-29 | 2025-05-22 | 120,384 | $1.70 | $204.7K | 194,824 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-22 | 120,384 | $8.92 | $1.07M | 74,440 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-04-29 | 2025-05-22 | 39,616 | $8.92 | $353.4K | 74,440 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-04-27 | 2025-04-29 | 500,000 | — | $0 | 600,000 | SEC↗ |
| SRRK Scholar Rock Holding Corp | A Award | 2025-04-27 | 2025-04-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2025-02-21 | 2025-02-24 | 303 | $10.08 | $3.1K | 49,129 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2025-01-23 | 2025-01-27 | 116 | $9.45 | $1.1K | 49,445 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2025-01-23 | 2025-01-27 | 13 | $9.94 | $129 | 49,432 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2025-01-10 | 2025-01-13 | 979 | $0.44 | $431 | 1,139,915 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-11-19 | 2024-11-20 | 3,186 | $0.55 | $1.8K | 1,140,894 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-11-05 | 2024-11-06 | 5,136 | $0.86 | $4.4K | 1,144,080 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-10-22 | 2024-10-23 | 1,882 | $0.77 | $1.4K | 1,149,216 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-10-21 | 2024-10-23 | 1,546 | $0.78 | $1.2K | 1,151,098 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-10-03 | 2024-10-04 | 940 | $0.81 | $761 | 1,152,644 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-08-19 | 2024-08-20 | 3,159 | $0.76 | $2.4K | 1,153,584 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-08-05 | 2024-08-07 | 5,251 | $0.73 | $3.8K | 1,156,743 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-07-22 | 2024-07-23 | 1,858 | $0.74 | $1.4K | 1,161,994 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-07-19 | 2024-07-23 | 1,542 | $0.75 | $1.2K | 1,163,852 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-07-02 | 2024-07-03 | 939 | $0.72 | $676 | 1,165,394 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-05-17 | 2024-05-21 | 3,143 | $0.75 | $2.4K | 1,129,996 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-05-03 | 2024-05-07 | 4,957 | $0.80 | $4.0K | 1,133,139 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2024-04-29 | 2024-04-30 | 240,000 | — | $0 | 240,000 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-04-22 | 2024-04-23 | 1,857 | $0.75 | $1.4K | 1,138,096 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-04-19 | 2024-04-23 | 1,521 | $0.75 | $1.1K | 1,139,953 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-04-02 | 2024-04-04 | 885 | $0.77 | $681 | 1,141,474 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-02-20 | 2024-02-22 | 2,893 | $0.70 | $2.0K | 1,142,359 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-02-05 | 2024-02-06 | 18,331 | $0.67 | $12.3K | 1,145,252 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-01-23 | 2024-01-25 | 3,205 | $0.67 | $2.1K | 1,163,583 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2024-01-04 | 2024-01-08 | 961 | $0.64 | $615 | 1,166,788 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-11-17 | 2023-11-21 | 2,490 | $1.63 | $4.1K | 1,167,749 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-10-20 | 2023-10-23 | 1,475 | $1.54 | $2.3K | 1,170,239 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-10-19 | 2023-10-23 | 1,232 | $1.58 | $1.9K | 1,171,714 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-10-03 | 2023-10-05 | 755 | $1.98 | $1.5K | 1,172,946 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-08-17 | 2023-08-21 | 10,516 | $2.50 | $26.3K | 1,173,701 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-07-20 | 2023-07-21 | 1,437 | $3.35 | $4.8K | 1,184,217 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-07-19 | 2023-07-21 | 1,198 | $3.56 | $4.3K | 1,185,654 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-07-05 | 2023-07-06 | 2,983 | $3.05 | $9.1K | 1,186,852 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2023-04-28 | 2023-04-28 | 96,000 | — | $0 | 96,000 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-04-20 | 2023-04-21 | 1,466 | $3.63 | $5.3K | 1,185,055 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-04-19 | 2023-04-21 | 1,217 | $3.71 | $4.5K | 1,186,521 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2023-02-02 | 2023-02-03 | 292,500 | — | $0 | 1,012,362 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2023-02-02 | 2023-02-03 | 157,500 | — | $0 | 1,187,738 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-01-20 | 2023-01-23 | 1,426 | $5.14 | $7.3K | 1,030,238 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2023-01-19 | 2023-01-23 | 5,111 | $5.08 | $26.0K | 1,031,664 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-10-20 | 2022-10-26 | 1,449 | $9.36 | $13.6K | 1,036,775 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-10-19 | 2022-10-24 | 1,449 | $9.36 | $13.6K | 1,036,775 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-08-16 | 2022-08-17 | 100,000 | — | $0 | 1,038,224 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-28 | 2022-08-01 | 3,253,796 | $4.61 | $15.00M | 16,674,766 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-07-20 | 2022-07-21 | 1,432 | $5.21 | $7.5K | 938,224 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2022-07-01 | 2022-07-06 | 54,600 | — | $0 | 54,600 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-07-01 | 2022-07-06 | 29,400 | — | $0 | 939,656 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2022-04-28 | 2022-04-29 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-04-20 | 2022-04-22 | 1,162 | $6.68 | $7.8K | 906,633 | SEC↗ |
| ALVR Allovir, Inc. | S Sale | 2022-01-20 | 2022-01-24 | 6,450 | $8.75 | $56.4K | 858,957 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2022-01-18 | 2022-04-04 | 119,162 | — | $0 | 119,162 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2022-01-18 | 2022-04-04 | 48,838 | — | $0 | 907,795 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2021-08-09 | 2021-08-10 | 64,000 | — | $0 | 64,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-05-04 | 2021-05-05 | 10,016 | $0.84 | $8.4K | 74,440 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-02-01 | 2021-02-03 | 10,224 | $0.99 | $10.1K | 84,456 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2021-01-19 | 2021-01-21 | 109,200 | — | $0 | 109,200 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2021-01-19 | 2021-01-21 | 58,800 | — | $0 | 865,407 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion deriv | 2020-08-03 | 2020-08-05 | 20,000,000 | — | $0 | 0 | SEC↗ |
| ALVR Allovir, Inc. | C Conversion | 2020-08-03 | 2020-08-05 | 13,420,970 | — | $0 | 13,420,970 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2020-07-29 | 2020-07-31 | 436,900 | — | $0 | 436,900 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-08-08 | 2016-08-10 | 277 | $137.14 | $38.0K | 178,463 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 2 | $141.23 | $282 | 178,740 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-29 | 2016-03-01 | 1,120 | $138.91 | $155.6K | 178,742 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2016-02-26 | 2016-03-01 | 31,000 | $140.16 | $4.34M | 31,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-26 | 2016-03-01 | 8,000 | — | $0 | 179,862 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 287 | $132.02 | $37.9K | 175,465 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 3,487 | $138.02 | $481.3K | 171,862 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-08 | 2016-02-08 | 116 | $139.23 | $16.2K | 175,349 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 500 | $144.36 | $72.2K | 176,806 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 300 | $145.37 | $43.6K | 177,306 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 100 | $146.22 | $14.6K | 177,606 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 200 | $143.51 | $28.7K | 176,606 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 435 | $142.25 | $61.9K | 176,171 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-05 | 2016-02-08 | 419 | $141.79 | $59.4K | 175,752 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-04 | 2016-02-08 | 692 | $143.81 | $99.5K | 165,954 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-02-04 | 2016-02-08 | 11,763 | — | $0 | 177,706 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2016-02-04 | 2016-02-08 | 11 | $145.40 | $1.6K | 165,943 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-08-04 | 2015-08-05 | 675 | $196.52 | $132.7K | 166,646 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-03-02 | 2015-03-03 | 487 | $180.34 | $87.8K | 167,321 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-02-27 | 2015-03-03 | 24,400 | — | $0 | 24,400 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-27 | 2015-03-03 | 5,100 | — | $0 | 167,808 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-10 | 2015-02-12 | 1,985 | $171.15 | $339.7K | 162,708 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-09 | 2015-02-09 | 2,701 | $174.18 | $470.5K | 164,695 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-09 | 2015-02-09 | 2 | $175.09 | $350 | 164,693 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-02-05 | 2015-02-09 | 11,690 | — | $0 | 167,396 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-04 | 2015-02-05 | 676 | $174.37 | $117.9K | 155,706 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2015-02-03 | 2015-02-05 | 895 | $174.06 | $155.8K | 156,382 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-18 | 2014-12-19 | 5,493 | $182.08 | $1.00M | 157,277 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-12-03 | 2014-12-04 | 20,000 | $20.90 | $418.0K | 100,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-12-03 | 2014-12-04 | 30,000 | $17.98 | $539.4K | 1,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 3,447 | $199.53 | $687.8K | 180,110 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 3,468 | $198.28 | $687.6K | 183,557 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 3,438 | $197.45 | $678.8K | 187,025 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 9,037 | $196.46 | $1.78M | 190,463 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 200 | $202.76 | $40.6K | 162,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-12-03 | 2014-12-04 | 20,000 | $20.90 | $418.0K | 212,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-12-03 | 2014-12-04 | 30,000 | $17.98 | $539.4K | 192,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 5,782 | $200.82 | $1.16M | 174,328 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 11,358 | $201.79 | $2.29M | 162,970 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-03 | 2014-12-04 | 13,270 | $195.55 | $2.59M | 199,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-12-02 | 2014-12-04 | 25,000 | $17.98 | $449.5K | 31,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-12-02 | 2014-12-04 | 25,000 | $200.16 | $5.00M | 162,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-12-02 | 2014-12-04 | 25,000 | $17.98 | $449.5K | 187,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-06 | 2014-11-10 | 5,693 | — | $0 | 56,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-06 | 2014-11-10 | 5,693 | $17.98 | $102.4K | 168,463 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-06 | 2014-11-10 | 5,693 | $195.00 | $1.11M | 162,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-11-03 | 2014-11-04 | 30,000 | $17.98 | $539.4K | 62,525 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 1,400 | $192.60 | $269.6K | 163,859 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 8,231 | $191.40 | $1.58M | 165,259 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 19,280 | $190.56 | $3.67M | 173,490 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-11-03 | 2014-11-04 | 30,000 | $17.96 | $538.8K | 192,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-11-03 | 2014-11-04 | 1,089 | $193.36 | $210.6K | 162,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-31 | 2014-11-04 | 17,475 | $17.98 | $314.2K | 92,525 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2014-10-31 | 2014-11-04 | 1,832 | $17.65 | $32.3K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-10-31 | 2014-11-04 | 19,307 | $195.18 | $3.77M | 162,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-31 | 2014-11-04 | 17,475 | $17.96 | $313.9K | 182,077 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2014-10-31 | 2014-11-04 | 1,832 | $17.65 | $32.3K | 164,602 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-08-04 | 2014-08-05 | 1,525 | $157.82 | $240.7K | 162,770 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-02-28 | 2014-03-04 | 49,200 | $176.80 | $8.70M | 49,200 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-28 | 2014-03-04 | 4,000 | — | $0 | 164,295 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 20 | $157.47 | $3.1K | 137,900 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-07 | 2014-02-10 | 1,600 | $155.55 | $248.9K | 137,920 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-02-06 | 2014-02-10 | 9,745 | — | $0 | 139,520 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-04 | 2014-02-05 | 2,700 | $153.63 | $414.8K | 129,775 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-02-03 | 2014-02-05 | 852 | $157.14 | $133.9K | 132,475 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-01-29 | 2014-01-31 | 94 | $133.37 | $12.5K | 133,327 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2014-01-29 | 2014-01-31 | 900 | $133.44 | $120.1K | 133,421 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-12-18 | 2013-12-20 | 32,026 | $17.65 | $565.3K | 1,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-12-18 | 2013-12-20 | 32,026 | $17.65 | $565.3K | 166,347 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-12-18 | 2013-12-20 | 32,026 | $127.81 | $4.09M | 134,321 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-12-09 | 2013-12-11 | 17,974 | $17.65 | $317.2K | 33,858 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-12-09 | 2013-12-11 | 17,974 | $127.66 | $2.29M | 134,321 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-12-09 | 2013-12-11 | 17,974 | $17.65 | $317.2K | 152,295 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-10-28 | 2013-10-30 | 50,000 | $17.65 | $882.5K | 51,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 42,138 | $122.80 | $5.17M | 318,670 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-10-28 | 2013-10-30 | 7,862 | $123.85 | $973.7K | 310,808 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-10-28 | 2013-10-30 | 50,000 | $17.65 | $882.5K | 360,808 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-08-05 | 2013-08-07 | 852 | $116.87 | $99.6K | 310,808 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-30 | 2013-08-01 | 995 | $110.86 | $110.3K | 311,660 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-07-12 | 2013-07-16 | 12,504 | $17.65 | $220.7K | 101,832 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2013-07-12 | 2013-07-16 | 37,496 | $11.92 | $447.0K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-12 | 2013-07-16 | 12,504 | $17.65 | $220.7K | 362,655 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-07-12 | 2013-07-16 | 50,000 | $120.00 | $6.00M | 312,655 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2013-07-12 | 2013-07-16 | 37,496 | $11.92 | $447.0K | 350,151 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2013-02-06 | 2013-02-08 | 60,800 | — | $0 | 60,800 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2013-02-06 | 2013-02-08 | 4,500 | — | $0 | 312,655 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 70 | $96.54 | $6.8K | 308,155 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 2,311 | $95.61 | $221.0K | 309,327 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-02-04 | 2013-02-06 | 1,102 | $96.17 | $106.0K | 308,225 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-01-29 | 2013-01-30 | 975 | $94.32 | $92.0K | 311,638 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2013-01-28 | 2013-01-30 | 1,007 | $94.50 | $95.2K | 312,613 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-31 | 2012-07-31 | 900 | $104.94 | $94.4K | 313,620 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 30,000 | — | $0 | 37,496 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 17,891 | $109.37 | $1.96M | 315,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 868 | $106.14 | $92.1K | 314,520 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 12,109 | $108.39 | $1.31M | 333,279 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 30,000 | $11.92 | $357.6K | 345,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-04-26 | 2012-04-30 | 1,667 | $89.90 | $149.9K | 315,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-04-26 | 2012-04-30 | 46,333 | $89.98 | $4.17M | 317,055 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-03-20 | 2012-03-22 | 21,996 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-03-20 | 2012-03-22 | 21,996 | $10.29 | $226.3K | 385,384 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-03-20 | 2012-03-22 | 21,996 | $89.93 | $1.98M | 363,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-14 | 2012-02-15 | 20,000 | — | $0 | 21,996 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-14 | 2012-02-15 | 20,000 | $10.29 | $205.8K | 383,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-14 | 2012-02-15 | 20,000 | $84.95 | $1.70M | 363,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-13 | 2012-02-15 | 20,000 | — | $0 | 41,996 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-13 | 2012-02-15 | 20,000 | $10.29 | $205.8K | 383,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-13 | 2012-02-15 | 20,000 | $84.34 | $1.69M | 363,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-03 | 2012-02-06 | 86,500 | — | $0 | 86,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-03 | 2012-02-06 | 11,000 | — | $0 | 363,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-30 | 2012-01-30 | 3,480 | $74.51 | $259.3K | 352,388 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-27 | 2012-01-30 | 863 | $74.41 | $64.2K | 355,868 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-10 | 2012-01-11 | 1,036 | $75.00 | $77.7K | 356,731 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-01-09 | 2012-01-11 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-01-09 | 2012-01-11 | 5,664 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-01-09 | 2012-01-11 | 20,000 | $5.18 | $103.6K | 372,103 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-01-09 | 2012-01-11 | 5,664 | $17.65 | $100.0K | 377,767 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-09 | 2012-01-11 | 20,000 | $75.55 | $1.51M | 357,767 | SEC↗ |